Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Avelumab receives FDA fast track designation for metastatic Merkel cell carcinoma

Oct. 8, 2015

GreenPeptide files IND for cancer peptide vaccine GRN-1201

Oct. 8, 2015

MedImmune initiates phase I study of MEDI-9197 for solid tumor cancers

Oct. 8, 2015

FDA places clinical hold on axalimogene filolisbac

Oct. 7, 2015

Biosimilar ONS-1045 meets primary and secondary endpoints in phase I trial

Oct. 7, 2015

Nivolumab shows enhanced overall survival in mRCC patients

Oct. 6, 2015

FDA approves Keytruda and companion diagnostic for PD-L1-expressing NSCLC tumors

Oct. 5, 2015

MedImmune and 3M Drug Delivery Systems collaborate to develop next-generation TLR agonists

Sep. 30, 2015

Advaxis initiates phase I study of ADXS-HER2 for HER2-expressing solid tumors

Sep. 30, 2015

CIRM grants USD 19.9 million to ImmunoCellular for the funding of ICT-107

Sep. 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...